The Global Molecular Biology Enzymes, Kits & Reagents Market is Expected to Reach at $5,420.63 million in 2018 - New Research Report by MarketsandMarkets
(PRWEB) October 26, 2014 -- The “Molecular Biology Enzymes, Kits, & Reagents Market, Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) – Global Forecast to 2018” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global molecular biology enzymes, kits & reagents market along with the estimates and forecasts of the revenue and market share analysis.
The global molecular biology enzymes, kits & reagents market was valued at $2,847.63 million in 2013. This market is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018.
Speak to Analyst for More Info @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=164131709
The global molecular biology enzymes market comprises of the applications, end-user and products segments. The application segments included in this report are cloning, epigenetics, PCR (polymerase chain reactions), restriction digestion, sequencing, and other applications. The PCR applications segment had the largest share of the global market. The end-user segments included in this report are academic research institutes, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, and other end users.
The product segments included in this report are enzymes, and kits & reagents. The enzymes segment is divided into the ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptases, and other enzymes sub-segments. The ligase enzyme sub-segment is further divided into T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase enzyme sub-segment is divided into high fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases, while the restriction endonuclease enzyme sub-segment is divided into BamHI, EcoRI, PstI, and other restriction endonucleases.
The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and U.S. RoW encompasses Latin America, Middle East and Africa, and the Pacific countries.
Get PDf Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=164131709
The key drivers for this market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population. As this segment of the world population is more susceptible to chronic diseases, research into these ailments will become more significant, driving the growth of the molecular biology enzymes, kits & reagents market.
The report provides qualitative insights on key market shares, growth rates, and market drivers for all important sub-segments. It maps market sizes and growth rates of each sub-segment and identifies the segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the molecular biology enzymes, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.
The major players in the molecular biology enzymes, kits and reagents market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-spectroscopy-market-50034395.html
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets
Pankaj Sharma, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article